Heplisav-b 20 MCG/0.5 ML syrng 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FNQ3U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,174
Award facts
- Contract value 100% obligated
- $1,173.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,173.57 to AmerisourceBergen Drug Corp for HEPLISAV-B 20 MCG/0.5 ML syringes on December 18, 2025, with completion scheduled for December 19, 2025. This competitively awarded, firm fixed-price contract requires performance at AmerisourceBergen's Conshohocken, Pennsylvania location. HEPLISAV-B is a recombinant hepatitis B vaccine indicated for adult immunization, representing a critical pharmaceutical commodity for military and federal healthcare programs. The contract carries no set-aside designation, reflecting open competition among qualified vendors.
This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying comprehensive pharmaceutical products and medical supplies to support military healthcare systems worldwide. The company's substantial IDC with DLA enables flexible fulfillment of diverse medical supply requirements across multiple therapeutic domains, supporting military personnel and veterans through the Defense Health Agency and other federal healthcare entities.
Quick answers
Who was awarded contract SPE2DR26FNQ3U?
SPE2DR26FNQ3U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26FNQ3U worth?
The government has obligated $1,174 on SPE2DR26FNQ3U.
Is contract SPE2DR26FNQ3U an order under another contract?
Yes. SPE2DR26FNQ3U is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNQ3U competed?
The extent of competition for SPE2DR26FNQ3U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award